CLINICAL TRIALS

Advancement of clinical and microbiological research for diagnosis and treatment effects.

LABORATORY SERVICES

Standardised clinical trial services in pre-analytical, analytical and post-analytical procedures.

DATA MANAGEMENT

Initiation and deployment of clinical trials data base management systems.

GOOD CLINICAL PRACTICE

Accredited theory based modules with practical training for clinicians and support staff.

Welcome to TASK!

About Us

TASK Applied Science (TASK) is a clinical research centre in Cape Town, South Africa with a focus on performing clinical trials in tuberculosis (TB). TASK provides assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis, as well as for other prevalent diseases such as asthma, osteoarthritis and vaccine studies like respiratory syncytial virus (RSV), where new and improved treatments are urgently needed.

The company was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel anti-tuberculosis drugs. TASK mainly collaborates with international NGOs, government funded consortia, academic centers and pharmaceutical companies on various drug development projects.

TASK now employs over 180 staff members, has invested in state of the art bio-safety level 3 laboratory capacity as well as a network of clinical sites in Cape Town.

 

Vision and Mission

Better healthcare starts with us. TASK provides a platform for the development of novelties in healthcare that benefit the community.

Values

We want to be excellent. Do our work right and on time, every time. We own up, learn, and improve each day. We are TASK.

Resources

The Western Cape is among the areas with the highest Tuberculosis cases worldwide and we have years of experience in Tuberculosis  Research.

We believe in community

COMMUNITY ENGAGEMENT PROJECTS
  • Kids In Action

    The focus was to encourage adults in the community to seek knowledge.

  • Delft WIFI

    TASK is one of the Main Sponsors for the DELFT PUBLIC WIFI Project.

Current Treatment Stand

Furthermore, TB is increasingly becoming resistant to the current treatment

New TB Drugs In The Pipeline

There are currently at least 12 drugs in various stages of clinical evaluation for TB

Clinical Studies

We do many clinical studies, click to read more about it.

Asthma Trials

We are looking for children and adults to participate.

TB Research

Tuberculosis is one of the major causes of disability and death worldwide.

TB RESEARCH

Tuberculosis is one of the major causes of disability and death worldwide.
Over 95% of TB deaths occur in low- and middle-income countries, according to the World Health Organization. In 2014, 9.6 million people became ill with TB and 1.5 million people died from the disease.
TB is a leading cause of death for people infected with HIV.
In 2015, 1 in 3 HIV deaths was due to TB. Globally in 2014, an estimated 480, 000 people developed multidrug-resistant TB (MDR-TB).
TASK is part of the global research community that is committed to finding new ways to better understand, diagnose, treat, and ultimately prevent TB.

RECENT NEWS & EVENTS